Company Filing History:
1 out of 2,405 
1 out of 2 Years Active: 2023
Title: Het P Patel: Innovator in Cancer Treatment
Introduction
Het P Patel is a notable inventor based in Groton, CT, who has made significant contributions to the field of cancer treatment. He holds a patent that focuses on a synthetic pathway to belzutifan, a crucial HIF-2α inhibitor. This innovation is particularly relevant in the ongoing battle against cancer, showcasing Patel's commitment to advancing medical science.
Latest Patents
Patel's most recent patent is titled "Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates." This patent provides valuable crystalline forms for certain synthetic intermediates used in the production of belzutifan. The disclosure also outlines processes for isolating these crystalline forms, which are essential for the effective synthesis of this important cancer treatment.
Career Highlights
Throughout his career, Het P Patel has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in drug development.
Collaborations
Patel has collaborated with several professionals in his field, including Stephen M Dalby and Clinton Scott Shultz. These partnerships have likely enhanced his research and development efforts, leading to impactful advancements in cancer treatment.
Conclusion
Het P Patel is a distinguished inventor whose work in developing a synthetic pathway to belzutifan represents a significant advancement in cancer therapy. His contributions to the pharmaceutical industry and collaborations with other experts highlight his dedication to improving patient outcomes.